default author photo

Sweety Samal

Government of India - Infection and Immunology Center

SCHOLARLY PAPERS

3

DOWNLOADS

1,057

TOTAL CITATIONS

6

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Cellular Immune Responses are Preserved and May Contribute to Chadox1 ChAdOx1 nCoV-19 Vaccine Effectiveness Against Infection Due to SARS-CoV-2 B·1·617·2 Delta Variant Despite Reduced Virus Neutralisation

Number of pages: 42 Posted: 16 Jul 2021
Ramachandran Thiruvengadam, Amit Awasthi, Guruprasad Medigeshi, Sankar Bhattacharya, Shailendra Mani, Sridhar Sivasubbu, Tripti Srivatsava, Sweety Samal, Deepika Rathna Murugesan, Bapu Koundinya Desiraju, Pallavi Kshetrapal, Rajesh Pandey, Vinod Scaria, Praveen Kumar Malik, Juhi Taneja, Akshay Binayke, Tarini Vohra, Aymaan Zaheer, Deepak Rathore, Naseem Ahmed Khan, Heena Shaman, Shubbir Ahmed, Rajesh Kumar, Suprit Deshpande, Chandru Subramani, Nitya Wadhwa, Nimesh Gupta, Anil K. Pandey, Jayanta Bhattacharya, Anurag Agrawal, Sudhanshu Vrati, Shinjini Bhatnagar, Pramod Kumar Garg and DBT Consortium for COVID-19 Research
Translational Health Science and Technology Institute, Government of India - Immuno-biology Lab, Government of India - Translational Health Science & Technology Institute (THSTI), Translational Health Science and Technology Institute, Government of India - Infection and Immunology Center, CSIR-Institute of Genomics and Integrative Biology, Translational Health Science and Technology Institute, Government of India - Infection and Immunology Center, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, CSIR-Institute of Genomics and Integrative Biology, CSIR-Institute of Genomics and Integrative Biology, ESIC Medical College and Hospital, ESIC Medical College and Hospital, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Government of India - Vaccine and Infectious Disease Research Center, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute, Regional Center for Biotechnology, Translational Health Science and Technology Institute, National Institute of Immunology, ESIC Medical College and Hospital, Translational Health Science and Technology Institute, CSIR-Institute of Genomics and Integrative Biology, Regional Center for Biotechnology, Translational Health Science and Technology Institute, Translational Health Science and Technology Institute and Independent
Downloads 826 (73,650)
Citation 6

Abstract:

Loading...

2.

Omicron Sub-Lineage BA.5 Infection Causes Attenuated Pathology and Results in Robust Protection in Omicron Recovered hACE2 Transgenic Mice

Number of pages: 49 Posted: 10 Oct 2022
ZAIGHAM ABBAS RIZVI, Neeta Adhikari, Kritika Sharma, Srikanth Sadhu sadhu, Jyotsna Dandotiya, Ritika Khatri, Virendra Singh, Vinayakdas K.V., Sweety Samal, Shailendra Mani and Amit Awasthi
Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Infection and Immunology Center, Government of India - Immuno-biology Lab, Government of India - Immuno-biology Lab, Government of India - Infection and Immunology Center, Government of India - Infection and Immunology Center and Government of India - Immuno-biology Lab
Downloads 161 (464,454)

Abstract:

Loading...

BA.5, Omicron sub-variants, Variant of concern, COVID-19, SARS-CoV-2, hACE2.Tg mice, re-infection

3.

RBD Decorated PLA Nanoparticle Admixture with Aluminium Hydroxide Elicit Robust and Long Lasting Immune Response Against SARS-CoV-2

Number of pages: 30 Posted: 17 Feb 2022
Jairam Meena, Priyank Singhvi, Sudeepa Srichandan, Jyotsna Dandotiya, Juhi Verma, Mamta Singh, Rahul Ahuja, Neha Panwar, Ritika Khatri, Gazala Siddiqui, Sweety Samal, Amulya Kumar Panda and Anuradha Gupta
National Institute of Immunology - Product Development Cell, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, National Institute of Immunology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of India - Infection and Immunology Center, National Institute of Immunology - Product Development Cell and affiliation not provided to SSRN
Downloads 70 (875,328)

Abstract:

Loading...

Receptor binding domain, SARS-CoV-2 vaccine, Polymeric nanoparticles, memory antibody response, virus neutralization, protein-subunit vaccine, COVID-19 vaccine